Mankind Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 25	Sep ' 24	Sep ' 23	Sep ' 22

Sales

5,150.14

4,933.00

4,753.56

4,318.80

Operating profit

1,366.26

1,324.23

1,174.66

942.72

Interest

293.90

8.18

6.28

17.62

Gross profit

1,214.25

1,516.64

1,283.94

1,013.03

EPS (Rs)

21.12

28.66

22.02

17.93

Other income

141.89

200.59

115.55

87.92

Stock adjustment

77.87

15.23

17.83

218.14

Raw material

455.22

386.36

443.38

385.72

Power and fuel

-

-

-

-

Employee expenses

1,185.16

1,047.96

981.49

849.83

Excise

-

-

-

-

Admin and selling expenses

-

-

-

-

Research and development expenses

-

-

-

-

Expenses capitalised

-

-

-

-

Other expenses

2,065.63

2,159.22

2,136.19

1,922.39

Provisions made

-

-

-

-

Depreciation

195.96

168.82

145.58

131.26

Taxation

146.63

261.13

256.19

163.37

Net profit / loss

871.66

1,147.92

882.17

718.40

Extra ordinary item

-

61.23

-

-

Prior year adjustments

-

-

-

-

Equity capital

41.28

40.06

40.06

40.06

Equity dividend rate

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

OPM (%)

26.53

26.84

24.71

21.83

GPM (%)

22.94

29.54

26.37

22.99

NPM (%)

16.47

22.36

18.12

16.30